While in type 1 diabetes, β-cells are destroyed by a β-cell-specific autoimmune process [3], in type 2 diabetes, as well as in obesity-linked type 2 diabetes, β-cells are dysfunctional as they are no longer able to adapt to the elevated insulin demand caused by systemic insulin resistance [4]. This evidence concerns the gene INS and type 2 diabetes mellitus.